Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
BPC-157 significantly promotes angiogenesis by enhancing vascular endothelial growth factor receptor-2 (VEGFR2) activity and nitric oxide signaling through activation of the Akt-endothelial nitric oxide synthase (eNOS) pathway
Each step during preparation influences patient safety outcomes significantly
BPC-157 stands for Body Protection Compound-157, which mirrors a natural protein found in your stomach that plays a role in healing and regeneration
The same documentation standard applies to related unspecified codes, including H11.9 (unspecified disorder of conjunctiva), H18.9 (unspecified disorder of cornea), and H01.9 (unspecified inflammation of eyelid)
## **Other relevant codes** - **J2357** - Injection, omalizumab, 5 mg ## **Reference** Moda Health Plan, Inc
Supplied as lyophilised powder, third-party tested
US$ 28.08
US$ 23.73
US$ 29.10
US$ 26.05
